Mirae Asset Global Investments Co., Ltd. Verona Pharma PLC Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Verona Pharma PLC stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,610 shares of VRNA stock, worth $141,749. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,610
Previous 2,081
25.42%
Holding current value
$141,749
Previous $30,000
150.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VRNA
# of Institutions
169Shares Held
68.7MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$343 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$303 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$272 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$229 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$193 Million14.95% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.31B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...